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FEATURE ARTICLE
The Paradigm of Huntington Dise
John B. Jenkins* and P. Michael Conneallyt
Department of Biology, Swarthmore College, Swarthmore, PA;
and tDepartment of Medical Genetics, Indiana University Medical
Center, Indianapolis

I recall it as vividly as though it had occurred but yesterday. It made a most enduring impression upon my boyish mind which was my very first impulse to choosing
chorea as my virgin contribution to medical lore. Driving with my father through a wooded road leading from
East Hampton to Amagansett we suddenly came upon
two women, mother and daughter, both tall and thin,
almost cadaverous, both bowing, twisting, grimacing.
I stared in wonderment, almost in fear. What could it
mean? My father paused to speak with them and we
passed on. Then my Gamaliel-like instruction began; my
medical education had its inception. From this point on,
my interest in the disease has never wholly ceased. [George
Huntington, at 59, recalling how at the age of 8 years
he first saw Huntington disease while traveling with his
physician father on his professional rounds in 1858].

Introduction

Huntington disease (HD) is an incurable late-onset autosomal dominant disorder characterized by degeneration of the nervous system. Characteristic features of
HD include involuntary choreic movements (in the
United Kingdom, the disorder is referred to as Huntington chorea), the impairment of cognitive functions,
and behavioral changes. Each child of an affected person has a 50% chance of inheriting the defective gene.
The penetrance of the defective allele is 100%; thus,
all individuals who inherit it manifest symptoms of the
disease and ultimately succumb to its effects, unless they
die of other causes. Though relatively rare (about 4-8
cases/ 100,000 people), it is among the most mysterious and peculiarly distressing of genetic disorders. Part
of the mystery lies in how the HD gene can cause the
programmed death of a specific subset of brain cells.
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The HD gene was localized to chromosome 4 in 1983
by Gusella et al. (1983). This identification was made
possible by the use of an RFLP, a DNA marker that
was found to be closely linked to the HD locus. The
RFLP is one of the most powerful tools available today
to detect defective alleles.
The Gusella et al. paper was seminal. It was the first
in a series of important papers that have been steadily
unraveling the mystery of the gene that causes HD. That
paper and the several that have since followed illustrate
many important genetic concepts, one of which is the
association between a phenotype and a specific genotype. There is a great deal of interest today in the links
between the genotype and neurological function. With
HD we have a single-gene locus that when mutated
causes a neurodegenerative disorder, a disorder associated with a specific subset of brain cells (basal ganglia and cerebral cortex). HD illustrates other things
as well. It exemplifies the integrative approach to
genetics by bringing to bear on a specific problem the
tools of molecular, classical, and population genetics.
For this reason and others, HD can be used with great
effectiveness as a key pedagogical tool in human genetics
courses in medical schools, colleges, and universities.
The Genetics of HD
HD is inherited as an autosomal dominant trait. The
enormous Venezuelan kindred along the shores of Lake
Maracaibo and the smaller American kindred illustrate
the key features of autosomal dominant inheritance,
as seen in figure 1.
But HD illustrates much more than just simple autosomal dominant inheritance. Like many other autosomal dominant traits, it is a late-onset pleiotropic
disorder exhibiting variable expressivity in both the age
at symptom onset (2-80 years) and degree of cognitive
and emotional disorders. Furthermore, we find that
there is no evidence for genetic heterogeneity, since all
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A portion of the Venezuelan HD pedigree. Deceased individuals have a diagonal slash through the symbol. This pedigree
Figure I
illustrates autosomal dominant inheritance. The letters under the symbols refer to the D4S1O molecular marker haplotypes found in each
person. In the Venezuelan pedigree, haplotype C segregates with the HD allele. The person circled represents a recombination event between
the D4S1O locus and the HD locus (after Gusella 1984).

families studied who express the trait carry mutations
at the same locus on chromosome 4 (Folstein et al. 1985;
Haines et al. 1986).
HD allows us to discuss another important genetic
concept, that of multiple allelism. While all studies to
date indicate that there is a single locus responsible for
HD, given the diverse clinical features of the disease
in different families, we may well be looking at different allelic mutations at the same HD locus. A recent
study (Wolff et al. 1989) suggests that a new mutation
occurred at the HD locus in a large kindred. A woman
developed the symptoms of HD at age 36 years, and
they progressed for more than 14 years. Her parents,
who lived into their eighties, did not develop any symptoms; nor did any of her 15 living siblings, 13 of whom
were older. The most reasonable interpretation of this
pedigree is that a new mutation arose at the HD locus.
If this interpretation is correct, then this mutation is

a prime candidate for a new HD allele. Other interpretations of the clinical variability are, of course, possible. For example, the variable expressivity of HD may
be a consequence of differences in genetic background.
Also of interest here is the fact that HD is the only
genetically determined human trait known that shows
true Mendelian-dominant inheritance: homozygotes
and heterozygotes for the HD allele are phenotypically
indistinguishable. For most human dominant traits, the
homozygote is so severely affected that it does not usually survive to birth. An example ofthis is achondroplasia. That HD behaved as a true Mendelian dominant
was determined by identifying unions between individuals in the Venezuelan kindred who developed the symptoms for HD. The offspring from these unions were examined, and probable homozygotes were identified on
the basis of DNA markers. In one such mating that
produced 14 children, four children were identified as
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probable HD homozygotes (six were HD heterozygotes,
and four were not carrying the HD allele; this approximates a classic 1:2:1 Mendelian ratio). The probability
that none of the four is homozygous for HD is very
small (about 1/25,000), suggesting that homozygosity
for the HD allele does indeed exist in this family and
that it is not lethal in utero. There appear to be no phenotypic differences, either in age at onset, symptoms, or
progression of illness, between HD homozygotes and
HD heterozygotes (Wexler et al. 1987).
The Molecular Genetics of HD

In 1980, Botstein et al. (1980) published a theoretical paper on how RFLPs could be used to map gene
loci. RFLPs would be especially valuable tools in mapping gene loci -such as the HD locus, the cystic fibrosis (CF) locus, and others-whose products have yet
to be identified. This was a profound leap forward in
thinking about gene mapping. In its most intriguing
form, gene mapping with RFLPs involves linkage analysis of two gene loci, both of which encode unknown
products. One locus in the HD analysis is a segment
of DNA with no known function, detectable as being
polymorphic for restriction-enzyme sites. The other locus is the HD locus, whose cellular function continues
to elude us. These genetic markers are traced together
in families segregating for the HD allele. If the two loci
are linked, they will cosegregate; if unlinked, they will
assort independently.
The HD locus was the first autosomal locus to be
mapped using an RFLP (Duchenne muscular dystrophy,
an X-linked locus, was mapped in 1982 using RFLPs).
This remarkable feat was achieved by discovering a DNA
marker that cosegregated with HD. Though testing
hundreds of probes that detect RFLPs could have been
necessary based on the probability of finding close linkage to HD, Gusella and his colleagues fortuitously found
what they were looking for among the first 12 tested.
They discovered that the G8 sequence (now renamed
D4S10-D for DNA, 4 for chromosome 4, S for segment, and 10 for the order of identification of probes
mapping to chromosome 4) cosegregated with HD.
RFLP analysis illustrates several important features
of recombinant DNA technology and how it can be
used in a very positive way. The Gusella et al. (1983)
paper has a clear discussion of RFLPs. However, this
topic can be greatly expanded by the inclusion of other
readings (Gusella 1986).
It is valuable to contrast the use of RFLPs in the analysis of genes with unknown function, such as the HD
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gene, with the use of RFLPs in the analysis of genes
with known function, such as the beta-globin gene. For
example, the mutation for sickle cell anemia is found
in the sixth codon of the first exon of the beta gene;
this same mutation also destroys the recognition site
for the restriction enzyme MstII. Thus, the mutation
alters both a restriction site and the site coding for an
amino acid (Change and Kan 1982). With the D4S10
probe, we do not identify sequence variability in the
HD gene. As a matter of fact, the D4S10 sequence is
4-5 map units away from the HD locus. In the sickle
cell case, we can identify the beta-globin gene mutation with essentially 100% accuracy because the mutational change detected as an RFLP is the one causing
the disease. With HD, identification of the HD allele
is accomplished only by having the two separate variants linked -and thus is complicated by crossing-over
between HD and D4S10.
The D4SIO Allele Frequencies in the
Human Population

Population genetics, often given minimal coverage in
human and medical genetics courses, can be illustrated
clearly using the four different D4S10 haplotypes available. Each haplotype, A, B, C, and D, represents a differ-
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ent pattern of cleavage by the restriction enzyme HindIll
(fig. 2). Each pattern can be viewed as an allele comprised of the presence (+) or absence (-) of the polymorphic HindlIl restriction sites 1 and 2 at the D4S10
locus. Gusella et al. (1983) determined the frequencies
of these alleles in a sample of 23 unrelated people in
North America. Once these frequencies were determined, they calculated the four expected combinations,
i.e., + -, - +, + +, and - -, for the two variable sites.
Are the combinations of sites random for their frequencies, or is there some preferential association of sites
(e.g., is there is an advantage to having + +)? In other
words, is there evidence for linkage disequilibrium? No
evidence for linkage disequilibrium was found, but the
calculations allowing this conclusion are illustrative of
the very important principle of the Hardy-Weinberg
equilibrium.
The Integrative Strategy of Mapping
the HD Gene
Mapping the HD locus required more than finding
a DNA marker that cosegregated with HD. The D4S10

locus did indeed segregate with HD, but which autosome carried this DNA marker? The identification of
the specific autosome that carried D4S10 - and thus
HD -was achieved using somatic cell genetics, one of
the most important advances in the field of human
genetics.
Gusella et al. (1983) located the autosome that carries the D4S10 locus by looking at various human-mouse
cell hybrid lines. Only those cell lines that carried human chromosome 4 had the D4S10 sequence. This technique has been extremely important in localizing genes
whose function can be detected in the hybrid cell line.
Here, however, we have an instance where a gene locus
is identified on a specific chromosome even though it
produces no known product.
The HD locus was regionally localized on chromosome 4 when it was discovered that patients with WolfHirschhorn syndrome, a birth defect caused by the
deletion of part of the tip of the short arm of chromosome 4, were also missing the D4S10 sequence (Gusella
et al. 1985). This localized the HD locus to the tip of
chromosome 4 (fig. 3).
The D4S10 locus was localized more precisely using
the technique of in situ hybridization (Magenis et al.
1986). This powerful technique uses labeled D4S10
DNA as a probe to bind directly onto banded chromosomes held in place on a slide. The labeled probe binds

2:~-Huntington's

16

p

disease

15
0
-

13
21

-

Dysalbuminemic hyperzincemia
Dysalbuminemic hyperthyroxinemia
Analbuminemia
Hereditary persistence of alpha-fetoprotein
Dentinogenisis imperfecta-1

,Dysfinbrinogenemia/hypofibrinogenemia
causing hemorrhagic diathesis, thrombophilia
abnormal wound healing, repeated abortion

q

Sclerotylosis
?Anterior segment mesenchymal dysgenesis
JRieger syndrome
- Aspartylglucosaminuria

Phenylketonuria, atypical

4
Figure 3 Chromosome 4. The boxed entities are allelic disorders (after McKusick 1987).

to its homologous sequence on a specific chromosome.
Using four patients carrying different deletions in the
terminal region of 4p, Magenis and her colleagues found
that D4S10 localized to the distal half of band p16.1
of chromosome 4.
With D4S10-and, by inference, HD-localized to
the tip of chromosome 4, the task now becomes one
of analyzing the linkage relationship of HD to D4S10.
How close is D4S1O to the HD locus? Most students
will be familiar with the traditional types of linkage
analysis: the classic two- and three-point crosses. The
same principles that apply to those analyses also apply
to the mapping strategy for HD, but with important
embellishments. With HD, DNA markers identified as
RFLPs for the D4S1O locus are used in the linkage analysis. The lod score analysis (logarithm of the odds),
a powerful classical tool in human linkage studies, was
effectively used in the linkage analysis of the D4S1O locus and the HD locus. Lod score analysis is a mathematical statement of the probability of linkage between
two loci at some specified rate of recombination. The
distance between two linked loci is expressed as a recombination frequency. The establishment of linkage is determined by generating a lod score. The lod score is
calculated by evaluating the probability that an observed
pattern of allele segregation in a family occurred as a
consequence of independent assortment or linkage between two loci. While a detailed discussion of the lod
score technique and how it provides information about
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linkage may be beyond the scope of many human and
medical genetics courses, a general description of it emphasizes the importance of probability and traditional
mapping techniques in pedigree analysis (see Muench
1988).
With HD, it was originally estimated that D4S10 was
0 map units away from the HD locus, because no recombinants were found. In other words, the exciting possibility was raised that the D4S10 sequence was part of
the HD locus. However, as linkage studies were extended
to additional kindred members, some recombinants
were found (fig. 1), but the linkage remained close. Today lod score estimates suggest that D4S10 and HD are
about 4 map units apart. RFLPs closer to HD than
D4S10 have now been identified (Wasmuth et al. 1988;
Robbins et al. 1989). Two of these RFLPs (D4S95 and
D4S90) lie between D4S10 and the HD locus. The sequence of markers is now thought to be D4S10-D4S95D4S90-HD-telomere. As we find markers that map
closer and closer to HD, we approach the prospect of
having a marker that includes part of the HD gene sequence. An interesting problem for discussion at this
point might be this: if the difference between a normal
and mutant HD allele is a single base pair, or perhaps
a few base pairs, how will we know when we have in
fact isolated or entered the HD gene?
The mapping strategies used to locate the HD locus
are important. They reflect strategies used successfully
in the mapping of several other gene loci. These strategies include traditional techniques, molecular techniques, and somatic cell techniques.
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of carrying or not carrying the allele is approximately
95% rather than 100%. This complicates predictive
testing. The complications have become even greater
now that we know recombination can occur between
restriction stites within the D4S10 locus (Curtis et al.
1989). The accuracy of presymptomatic testing can be
increased by using multiple markers for the D4S10 locus and by using other RFLP loci as well.
A second issue is how individuals who are at 50%
risk for developing HD respond to the knowledge that
DNA probes can now be used to identify, with a high
degree of accuracy, the defective allele. On the basis
of recent studies, it is estimated that about two-thirds
of the people at risk for HD intend to seek predictive
testing, though the percentage of people at risk who
ultimately receive the testing is much less. A negative
test result reduces anxiety about developing HD and
clarifies the future for the person. A positive result in
a person poorly equipped to handle this information
can be devastating. For people at risk for HD, a minimum of 4 h of counseling and 8 h ofpsychological evaluation are typically involved in the procedure before the
communication of test results. In a recent study of 15
people at risk for HD (Meissen et al. 1988), four were
identified as probably having HD. The four individuals identified as having HD understandably experienced
depression but were not suicidal. The sample was small,
and much more data are needed in this area. Predictive
testing for HD when there is no cure or preventative
therapy is very difficult and requires great skill. Such
predictive testing raises several ethical issues that are
fruitful areas of discussion (Shaw 1987).

The Personal and Ethical Dilemmas of HD

Human genetics is an intensely personal discipline,
perhaps more so than any other scientific discipline.
It has as its goal the characterization of our genetic being. Identifying flaws in that genetic material requires
the appropriate scientific methodology as well as attention to the personal and ethical considerations of
the individuals and families involved. In medical genetics, no topic is charged with as much emotion or
controversy as the subject of prediction for the person
at risk for developing HD.
In families where HD is segregating, several important issues need to be addressed. One is the accuracy
of the presymptomatic testing procedure itself. There
is a possibility of crossing-over between HD and the
molecular marker, which means that the probability

Conclusion
HD illustrates several important genetic concepts.
These concepts include segregation and the lack of independent assortment as seen in pedigree analysis,
autosomal dominant inheritance patterns, late-onset
disorders, multiple allelism, variable expressivity, pleiotropism, recombinant-DNA techniques, molecular
mapping using RFLPs, Hardy-Weinberg equilibrium,
linkage disequilibrium, somatic cell genetics, lod score
analysis, probability, traditional mapping techniques,
the relationship between a phenotype and a genotype,
and the many personal, ethical, and societal dilemmas
that can be associated with human genetic diseases. HD
is extremely valuable as a teaching instrument in human and medical genetics courses.
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Appendix
Editor's Note: Supplemental Videotapes Available

Several related videotapes of excellent quality exist, and
they are strongly recommended for use in any educational setting where readers believe the contents of this
article appropriate. Each is available in 1/2" VHS by
contacting
Huntington's Disease Society of America
140 West 22d Street
New York, NY 10011
(212) 242-1968.
* "NOVA" program originally broadcast November
12, 1985, as part of "The Genetic Gamble" (HD
segment approximately 15 min). Visits to the Venezuelan families with Nancy Wexler, describes HD,
explains the pedigree analysis and DNA marker
work of James Gusella, and has an excellent description of how presymptomatic diagnosis is accomplished through Nancy Wexler's use of dominos to
exemplify linkage analysis.
* "60 Minutes" with Diane Sawyer, originally broadcast November 25, 1986 (14 min). Also shows the
Venezuelan families and describes HD, but emphasis is placed on the difficulty many at risk have in
making the choice of whether to use the presymptomatic test. The Wexler family discusses this process of decision making and considers the risk/reward ratio as a critical determinant.
* "West 57th Street" with Meredith Vieira, originally
broadcast June 2, 1987. (12 min). Discusses how
the Carrother's family has coped with the father
and a daughter dying from HD and how one of the
two children decided to have the presymptomatic
test. Describes the extensive process involved in using
the test, and the need for greater consideration of
the consequences of this and many other genetic
tests becoming available.
* "NOVA" program "Confronting the Killer Gene;"
originally broadcast March 28, 1989. (57 min). Focuses on four individuals from HD families, one

a child who is already affected, the other three being individuals at risk, including Arlo Guthrie and
Nancy Wexler. Each discusses how he or she came
to a decision as to whether to use the presymptomatic test. Also, James Gusella is interviewed, and
the Venezuelan families are shown.

The 1985 and 1989 "NOVA" programs can also be
purchased in 1/2" VHS for $99.00 and $250.00 respectively from
Cornet/MTI Films
108 Wilmot Road
Deerfield, IL 60015
(800) 621-2131
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